🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The majority of head and neck cancer patients do not respond to immunothera...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-02-23
Trial ID
NCT05787639
Treatments Being Tested
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab in...
Status
Active Not Recruiting
Location
Hoag Hospital
Start Date
2021-04-02
Trial ID
NCT04675294
Treatments Being Tested
I-SPY Phase I/Ib (I-SPY-P1) is an open-label, multisite platform study desi...
Status
Recruiting
Location
The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center
Start Date
2023-02-15
Trial ID
NCT05868226
Treatments Being Tested
This Phase 2 clinical study will evaluate evorpacept (ALX148) in combinatio...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2022-07-28
Trial ID
NCT05167409
Treatments Being Tested
The purpose of this umbrella study is to evaluate isatuximab when combined ...
Status
Recruiting
Location
Winship Cancer Institute of Emory University- Site Number : 8400010
Start Date
2021-01-25
Trial ID
NCT04643002
AT148007 is a Phase 1, open-label, multicenter, safety, pharmacokinetic, ph...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2022-11-02
Trial ID
NCT05524545
Treatments Being Tested
A Phase 2/3 Study of Evorpacept (ALX148) in Combination With Trastuzumab, R...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope & Innovation
Start Date
2022-01-15
Trial ID
NCT05002127
Treatments Being Tested
The Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter stu...
Status
Recruiting
Location
The University of Arizona Cancer Center - North Campus
Start Date
2025-12-10
Trial ID
NCT07007559
Treatments Being Tested
This Phase 1/2 clinical study will evaluate evorpacept (ALX148) in combinat...
Status
Terminated
Location
Northwestern University Feinberg School of Medicine
Start Date
2021-05-05
Trial ID
NCT04755244
Treatments Being Tested